Literature DB >> 25681002

The effect of light deprivation in patients with Stargardt disease.

Michel M Teussink1, Michele D Lee2, R Theodore Smith3, Ramon A C van Huet1, Caroline C Klaver4, B Jeroen Klevering1, Thomas Theelen5, Carel B Hoyng1.   

Abstract

PURPOSE: To investigate whether long-term protection from light exposure affects the rate of disease progression in patients with autosomal recessive Stargardt disease (STGD1), measured using fundus autofluorescence imaging.
DESIGN: Longitudinal, retrospective, interventional case series.
METHODS: Five patients with Stargardt disease protected 1 eye from light exposure by applying a black contact lens during waking hours for ≥12 months. Disease progression was followed by performing autofluorescence imaging at semi-regular intervals. Longitudinal changes in autofluorescence were studied by evaluating areas of decreased autofluorescence and areas of increased autofluorescence as a measure of retinal pigment epithelium damage and lipofuscin accumulation, respectively.
RESULTS: We observed less progression of decreased autofluorescence in 4 out of 5 light-protected eyes relative to their respective nonprotected eyes. The progression of increased autofluorescence, on the other hand, was highly variable and did not respond consistently to treatment.
CONCLUSIONS: Areas of decreased autofluorescence may serve as a useful biomarker for measuring the progression of Stargardt disease. The reduced progression of decreased autofluorescence in the light-protected eyes suggests that light deprivation might be beneficial in patients with Stargardt disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25681002     DOI: 10.1016/j.ajo.2015.02.004

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  Photodegradation of retinal bisretinoids in mouse models and implications for macular degeneration.

Authors:  Keiko Ueda; Jin Zhao; Hye Jin Kim; Janet R Sparrow
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

Review 2.  Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations.

Authors:  Frans P M Cremers; Winston Lee; Rob W J Collin; Rando Allikmets
Journal:  Prog Retin Eye Res       Date:  2020-04-09       Impact factor: 21.198

Review 3.  Juvenile Macular Degenerations.

Authors:  Pablo Altschwager; Lucia Ambrosio; Emily A Swanson; Anne Moskowitz; Anne B Fulton
Journal:  Semin Pediatr Neurol       Date:  2017-05-23       Impact factor: 1.636

4.  Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).

Authors:  Rupert W Strauss; Beatriz Muñoz; Alexander Ho; Anamika Jha; Michel Michaelides; Artur V Cideciyan; Isabelle Audo; David G Birch; Amir H Hariri; Muneeswar G Nittala; SriniVas Sadda; Sheila West; Hendrik P N Scholl
Journal:  JAMA Ophthalmol       Date:  2017-11-01       Impact factor: 7.389

Review 5.  Bisretinoid Photodegradation Is Likely Not a Good Thing.

Authors:  Keiko Ueda; Hye Jin Kim; Jin Zhao; Janet R Sparrow
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

6.  Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics.

Authors:  Janet R Sparrow
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 11.205

Review 7.  Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options.

Authors:  Preena Tanna; Rupert W Strauss; Kaoru Fujinami; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2016-08-04       Impact factor: 4.638

8.  Highly sensitive measurements of disease progression in rare disorders: Developing and validating a multimodal model of retinal degeneration in Stargardt disease.

Authors:  Stanley Lambertus; Nathalie M Bax; Ana Fakin; Joannes M M Groenewoud; B Jeroen Klevering; Anthony T Moore; Michel Michaelides; Andrew R Webster; Gert Jan van der Wilt; Carel B Hoyng
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

9.  Lipofuscin-associated photo-oxidative stress during fundus autofluorescence imaging.

Authors:  Michel M Teussink; Stanley Lambertus; Frits F de Mul; Malgorzata B Rozanowska; Carel B Hoyng; B Jeroen Klevering; Thomas Theelen
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

Review 10.  Towards Treatment of Stargardt Disease: Workshop Organized and Sponsored by the Foundation Fighting Blindness.

Authors:  Avery E Sears; Paul S Bernstein; Artur V Cideciyan; Carel Hoyng; Peter Charbel Issa; Krzysztof Palczewski; Philip J Rosenfeld; SriniVas Sadda; Ulrich Schraermeyer; Janet R Sparrow; Ilyas Washington; Hendrik P N Scholl
Journal:  Transl Vis Sci Technol       Date:  2017-09-14       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.